These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 739791)

  • 21. Influence of concomitant aspirin or prednisone on methotrexate synovial fluid concentration.
    Stewart CF; Christensen ML; Evens RP; Cremer M; Evans WE
    J Pharmacol Exp Ther; 1987 Oct; 243(1):131-7. PubMed ID: 3668846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase.
    Jolivet J; Chabner BA
    J Clin Invest; 1983 Sep; 72(3):773-8. PubMed ID: 6193143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined oral cyclosporin and methotrexate therapy in patients with rheumatoid arthritis elevates methotrexate levels and reduces 7-hydroxymethotrexate levels when compared with methotrexate alone.
    Fox RI; Morgan SL; Smith HT; Robbins BA; Choc MG; Baggott JE
    Rheumatology (Oxford); 2003 Aug; 42(8):989-94. PubMed ID: 12730515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue distribution of methotrexate in rats. A comparison between intravenous injection as bolus or drip infusion.
    Miglioli PA; Businaro V; Manoni F; Berti T
    Drugs Exp Clin Res; 1985; 11(4):275-9. PubMed ID: 3836130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A primate model for study of methotrexate pharmacokinetics in the central nervous system.
    Poplack DG; Bleyer WA; Wood JH; Kostolich M; Savitch JL; Ommaya AK
    Cancer Res; 1977 Jul; 37(7 Pt 1):1982-5. PubMed ID: 405092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early recognition of patients with decreased methotrexate clearance following high-dose methotrexate infusion therapy.
    Ikeda H; Kihira K; Kuwata N; Arai S; Kimura Y; Miyake K; Kitaura T; Fujimura K; Kuramoto A; Fukuchi H
    Hiroshima J Med Sci; 1996 Jun; 45(2):57-62. PubMed ID: 8810132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor and tissue distribution of a methotrexate-anti-EL4 immunoglobulin conjugate in EL4 lymphoma-bearing mice.
    Uadia P; Blair AH; Ghose T
    Cancer Res; 1984 Oct; 44(10):4263-6. PubMed ID: 6467187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bayesian calculation of methotrexate clearance after low dose intramuscular administration in patients with rheumatoid arthritis.
    Monjanel-Mouterde S; Lafforgue P; Blanc A; Catalin J; Aquaviva PC; Durand A
    J Rheumatol; 1998 Jul; 25(7):1276-81. PubMed ID: 9676756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time of exchange of 131I-labeled albumin between plasma and peripheral lymph in man.
    Engeset A; Aas M; Olszewski W; Sokolowski J
    Lymphology; 1979 Jun; 12(2):77-80. PubMed ID: 491741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits.
    Iven H; Brasch H; Engster J
    Cancer Chemother Pharmacol; 1985; 15(2):115-20. PubMed ID: 4017160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The protein binding and elimination of methotrexate after intravenous infusions in cancer patients.
    Paxton JW
    Clin Exp Pharmacol Physiol; 1982; 9(3):225-34. PubMed ID: 7140004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and organ distribution of methotrexate in the rat.
    Scheufler E; Zetler G; Iven H
    Pharmacology; 1981; 23(2):75-81. PubMed ID: 7312939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of the antibiotics piperacillin, doxycycline, and tobramycin on the pharmacokinetics of methotrexate in rabbits.
    Iven H; Brasch H
    Cancer Chemother Pharmacol; 1986; 17(3):218-22. PubMed ID: 3742705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of X-irradiation on the pharmacokinetics of methotrexate in rats: alteration of the blood-brain barrier.
    Storm AJ; van der Kogel AJ; Nooter K
    Eur J Cancer Clin Oncol; 1985 Jun; 21(6):759-64. PubMed ID: 4018118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concentration and pH dependent steady-state volume of distribution of methotrexate estimated by a simple physiologically based method.
    Lui CY; Lee MG; Chiou WL
    J Pharmacokinet Biopharm; 1984 Dec; 12(6):597-610. PubMed ID: 6533295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence of nonlinear pharmacokinetics of methotrexate in the rat.
    Scheufler E
    Pharmacology; 1982; 25(1):51-6. PubMed ID: 7122690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose methotrexate: preliminary evaluation of a pharmacokinetic approach.
    Monjanel S; Rigault JP; Cano JP; Carcassonne Y; Favre R
    Cancer Chemother Pharmacol; 1979; 3(3):189-96. PubMed ID: 527209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temocillin in peripheral lymph.
    Bergan T; Engeset A; Olszewski W
    J Antimicrob Chemother; 1983 Jul; 12(1):59-63. PubMed ID: 6619047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spatial distribution of dopamine, methotrexate and antipyrine during continuous intracerebral microperfusion.
    Sendelbeck SL; Urquhart J
    Brain Res; 1985 Mar; 328(2):251-8. PubMed ID: 4039212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of high-dose methotrexate in dogs. An experimental model with diffusion chambers.
    Porpaczy P; Schmidbauer CP; Georgopoulos A; Endler AT
    Cancer Chemother Pharmacol; 1983; 11(3):172-6. PubMed ID: 6640824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.